SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) APRIL 19, 1996
ENZON, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 0-12957 22-237286
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification)
20 KINGSBRIDGE ROAD, PISCATAWAY, NEW JERSEY 08854
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (908) 980-4500
(Former name or former address, if changed since last report)
<PAGE>
ITEM 5. OTHER EVENTS
On April 19, 1996, the Board of Directors (the "Board") of Enzon,
Inc. ("Enzon" or the "Company") elected Randy H. Thurman as Chairman of the
Company's Board of Directors.
Mr. Thurman has been a director of Enzon since 1993. He replaces
Dr. Abraham Abuchowski, a co-founder and/or director of Enzon since 1983.
Mr. Thurman most recently was Chairman and Chief Executive
Officer of Corning Life Sciences, a diversified health services company
specializing in contract pharmaceutical research and commercial laboratory
testing. Previously, Mr. Thurman was President of Rhone-Poulenc Rorer
Pharmaceuticals. He is also the founder and Chairman of Health Care
Strategies 2000, a global healthcare consulting company focusing on health
care strategy.
Mr. Thurman will serve in a non-executive role and provide
strategic guidance and assist in building relationships with leading
companies and institutions.
The Company also formed a Research and Development Steering
Committee which will direct the overall Research and Development strategy
reporting to Mr. Tombros. Joining Mr. Tombros on the Steering Committee is
Rosina B. Dixon, M.D., who previously held senior positions in Research and
Development with Ciba-Geigy and Schering-Plough. Dr. Dixon is a director
of Enzon. Richard Cooper, M.D., Chairman of Enzon's Scientific Advisory
Committee, Director of the Medical College of Wisconsin Health Policy
Institute and retired Dean of the Medical College of Wisconsin will also
serve on the Steering Committee, along with Dr. Robert Shorr, Enzon's vice
president of Research and Development. Dr. Abuchowski has relinquished all
of his responsibilities as an employee of Enzon and has resigned from the
Board of Directors.
On April 19, the Company received an inquiry from Nasdaq Market
Surveillance regarding market activity in the company's common stock on
Friday, April 19. The company has issued a press release stating that it
knows of no other corporate developments, aside from the matters involving
Dr. Abuchowski's parting with the Company, which would explain the trading
activities in the company's common stock on Friday, April 19.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Dated: April 23, 1996
ENZON, INC.
(Registrant)
By: /S/JOHN A. CARUSO
John A. Caruso
Vice President,
Business Development and
General Counsel